Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

NCT00307528 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Interventions

BIOLOGICAL: Pneumococcal vaccine GSK513026
BIOLOGICAL: Pneumovax 23™

Sponsor

GlaxoSmithKline